Related Experiment Video
Updated: May 23, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric
Kan Wang1, Xiaosheng Hu, Changqing Du
1Institute of Cardiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou 310003, People's Republic of China.
Abstract:
There is growing evidence suggesting that circulating fibrocytes (CFs) play a pivotal role in tissue repair and fibrosis. In contrast, in recent studies, angiotensin-(1-7) [Ang-(1-7)] has been shown to antagonize fibrosis. The purpose of this study was to examine the direct effect of Ang-(1-7) on CFs. Total mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation. Using laser scanning confocal microscopy, CFs were identified as adherent cells that stained positive for both CD34 and collagen-I. After 14 days of culture, CFs were stimulated with Ang-(1-7) at concentrations of 10 nM, 100 nM, 1 μM or 10 μM, in the absence and presence of pretreatment with A-779, N(G)-nitro-L-arginine methyl ester (L-NAME) or both, for 24, 48 or 72 h. The number of cells, cellular proliferation, and level of apoptosis were determined by hematoxylin and eosin staining, the Cell Counting Kit-8 (CCK8) assay and the annexin V/propidium iodide binding assay, respectively. The collagen content of CFs was measured by the concentration of hydroxyproline, which was detected using the enzymatic digestion method. The expression of endothelial nitric oxide synthase (eNOS) was assayed by western Blot analysis, while nitric oxide (NO) generation was detected using the Griess method. We found that Ang-(1-7) increases apoptosis and eNOS/NO production in CFs. In addition, Ang-(1-7) decreases the number, proliferative capacity and collagen-secretion of CFs in a concentration- and time-dependent manner. These data suggest that Ang-(1-7) suppresses the both the number and function of CFs possibly by increasing eNOS/NO production in the CFs.
Insights
Angiotensin-(1-7) [Ang-(1-7)] suppresses circulating fibrocytes (CFs) by increasing eNOS/NO production. This peptide reduces CF number, proliferation, and collagen secretion, indicating a potential therapeutic role in fibrotic diseases.
Area of Science:
- Cell Biology
- Immunology
- Pharmacology
Background:
- Circulating fibrocytes (CFs) are implicated in tissue repair and fibrosis.
- Angiotensin-(1-7) [Ang-(1-7)] exhibits antifibrotic properties.
- The direct impact of Ang-(1-7) on CFs remains to be fully elucidated.
Purpose of the Study:
- To investigate the direct effects of Ang-(1-7) on the biology of circulating fibrocytes (CFs).
- To determine the influence of Ang-(1-7) on CF number, proliferation, apoptosis, and collagen production.
- To explore the role of nitric oxide (NO) pathways in mediating Ang-(1-7)'s effects on CFs.
Main Methods:
- Isolation of peripheral blood mononuclear cells (MNCs) and identification of CFs (CD34+/collagen-I+).
- Stimulation of cultured CFs with varying concentrations of Ang-(1-7) and assessment of cell number, proliferation (CCK8), and apoptosis (Annexin V/PI).
- Measurement of collagen content (hydroxyproline), eNOS expression (Western Blot), and NO generation (Griess assay).
Main Results:
- Ang-(1-7) significantly increased apoptosis and eNOS/NO production in CFs.
- Ang-(1-7) dose- and time-dependently reduced CF number, proliferative capacity, and collagen secretion.
- Inhibition of NO pathways (A-779, L-NAME) partially blocked Ang-(1-7)'s effects.
Conclusions:
- Angiotensin-(1-7) directly suppresses the number and function of circulating fibrocytes.
- The antifibrotic effects of Ang-(1-7) on CFs may be mediated through enhanced eNOS/NO production.
- These findings suggest Ang-(1-7) as a potential therapeutic agent for fibrotic conditions.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Regulation of Angiogenesis and Blood Supply
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
